NVAX
Price
$7.00
Change
+$0.01 (+0.14%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
1.13B
19 days until earnings call
RXRX
Price
$5.85
Change
+$0.33 (+5.98%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
2.39B
25 days until earnings call
Interact to see
Advertisement

NVAX vs RXRX

Header iconNVAX vs RXRX Comparison
Open Charts NVAX vs RXRXBanner chart's image
Novavax
Price$7.00
Change+$0.01 (+0.14%)
Volume$15.45K
Capitalization1.13B
Recursion Pharmaceuticals
Price$5.85
Change+$0.33 (+5.98%)
Volume$178.23K
Capitalization2.39B
NVAX vs RXRX Comparison Chart in %
Loading...
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVAX vs. RXRX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVAX is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (NVAX: $7.00 vs. RXRX: $5.52)
Brand notoriety: NVAX: Notable vs. RXRX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVAX: 60% vs. RXRX: 101%
Market capitalization -- NVAX: $1.13B vs. RXRX: $2.39B
NVAX [@Biotechnology] is valued at $1.13B. RXRX’s [@Biotechnology] market capitalization is $2.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVAX’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • NVAX’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both NVAX and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVAX’s TA Score shows that 5 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • NVAX’s TA Score: 5 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, both NVAX and RXRX are a good buy in the short-term.

Price Growth

NVAX (@Biotechnology) experienced а -1.41% price change this week, while RXRX (@Biotechnology) price change was -3.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

NVAX is expected to report earnings on Nov 05, 2025.

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.39B) has a higher market cap than NVAX($1.13B). NVAX YTD gains are higher at: -12.935 vs. RXRX (-18.343). NVAX has higher annual earnings (EBITDA): 555M vs. RXRX (-524.77M). NVAX has more cash in the bank: 731M vs. RXRX (500M). RXRX has less debt than NVAX: RXRX (92.9M) vs NVAX (229M). NVAX has higher revenues than RXRX: NVAX (1.22B) vs RXRX (59.8M).
NVAXRXRXNVAX / RXRX
Capitalization1.13B2.39B47%
EBITDA555M-524.77M-106%
Gain YTD-12.935-18.34371%
P/E Ratio2.55N/A-
Revenue1.22B59.8M2,032%
Total Cash731M500M146%
Total Debt229M92.9M247%
FUNDAMENTALS RATINGS
NVAX: Fundamental Ratings
NVAX
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
30
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NVAXRXRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 26 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NVAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSSAX31.18N/A
N/A
Emerald Finance & Bking Innovt Fd A
GIIAX9.98N/A
N/A
Nationwide International Index A
IGVWX50.44N/A
N/A
Voya Global High Dividend Low Vol W
MGLKX16.49N/A
N/A
MFS Global Real Estate R2
TRNZX22.16N/A
N/A
T. Rowe Price International Stock Z